RLBCX
Price
$34.67
Change
+$0.03 (+0.09%)
Updated
May 22 closing price
Net Assets
237.69B
TBLIX
Price
$34.02
Change
-$0.01 (-0.03%)
Updated
May 22 closing price
Net Assets
1.37B
Interact to see
Advertisement

RLBCX vs TBLIX

Header iconRLBCX vs TBLIX Comparison
Open Charts RLBCX vs TBLIXBanner chart's image
American Funds American Balanced R3
Price$34.67
Change+$0.03 (+0.09%)
VolumeN/A
Net Assets237.69B
Transamerica Multi-Managed Balanced I
Price$34.02
Change-$0.01 (-0.03%)
VolumeN/A
Net Assets1.37B
RLBCX vs TBLIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RLBCX vs. TBLIX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBCX is a Buy and TBLIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 238B vs. TBLIX (1.37B). TBLIX pays higher dividends than RLBCX: TBLIX (1.85) vs RLBCX (1.70). RLBCX was incepted earlier than TBLIX: RLBCX (23 years) vs TBLIX (15 years). RLBCX (0.89) is less costly to investors than TBLIX (0.74). RLBCX is a more actively managed with annual turnover of: 44.00 vs. TBLIX (41.00). RLBCX has a lower initial minimum investment than TBLIX: RLBCX (250) vs TBLIX (1000000). RLBCX annual gain was more profitable for investors over the last year : 4.44 vs. TBLIX (1.33). RLBCX return over 5 years is better than : 36.27 vs. TBLIX (26.37).
RLBCXTBLIXRLBCX / TBLIX
Total Expense Ratio0.890.74120%
Annual Report Gross Expense Ratio0.890.74120%
Fund Existence23 years15 years-
Gain YTD1.8810.299630%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets238B1.37B17,410%
Annual Yield % from dividends1.701.8592%
Returns for 1 year4.441.33334%
Returns for 3 years21.6817.64123%
Returns for 5 years36.2726.37138%
Returns for 10 years49.7243.30115%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ULBI5.530.14
+2.60%
Ultralife Corp
RUN10.66N/A
N/A
Sunrun
AMCR9.05N/A
N/A
Amcor plc
UWMC3.97N/A
N/A
UWM Holdings Corp
LYRA0.09N/A
-1.70%
Lyra Therapeutics